Skip to Main content Skip to Navigation
Journal articles

Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion

Abstract : Aims: Liraglutide controls type 2 diabetes (T2D) and inflammation. Gut microbiota regulates the immune system and causes at least in part type 2 diabetes. We here evaluated whether liraglutide regulates T2D through both gut microbiota and immunity in dysmetabolic mice. Methods: Diet-induced dysmetabolic mice were treated for 14 days with intraperitoneal injection of liraglutide (100 µg/kg) or with vehicle or Exendin 4 (10 µg/kg) as controls. Various metabolic parameters, the intestinal immune cells were characterized and the 16SrDNA gene sequenced from the gut. The causal role of gut microbiota was shown using large spectrum antibiotics and by colonization of germ-free mice with the gut microbiota from treated mice. Results: Besides, the expected metabolic impacts liraglutide treatment induced a specific gut microbiota specific signature when compared to vehicle or Ex4-treated mice. However, liraglutide only increased glucose-induced insulin secretion, reduced the frequency of Th1 lymphocytes, and increased that of TReg in the intestine. These effects were abolished by a concomitant antibiotic treatment. Colonization of germ-free mice with gut microbiota from liraglutide-treated diabetic mice improved glucose-induced insulin secretion and regulated the intestinal immune system differently from what observed in germ-free mice colonized with microbiota from non-treated diabetic mice. Conclusions: Altogether, our result demonstrated first the influence of liraglutide on gut microbiota and the intestinal immune system which could at least in part control glucose-induced insulin secretion.
Document type :
Journal articles
Complete list of metadata
Contributor : Hélène Lesur <>
Submitted on : Thursday, March 25, 2021 - 12:12:38 PM
Last modification on : Friday, June 4, 2021 - 2:40:24 PM




Julie Charpentier, François Briand, Benjamin Lelouvier, Florence Servant, Vincent Azalbert, et al.. Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion. Acta Diabetologica, Springer Verlag, 2021, ⟨10.1007/s00592-020-01657-8⟩. ⟨hal-03180870⟩



Record views